Bernard Bihari, MD and Low Dose Naltrexone (LDN)
Low Dose Naltrexone (LDN) In 1984, the National Institute on Drug Abuse finished the development of naltrexone as an adjunct to treating heroin addicts. Its purpose was to block the heroin high with the hope that it would become a very useful treatment for heroin addicts. Dr Bernard Bihari during this time was a nationally …
Bernard Bihari, MD and Low Dose Naltrexone (LDN) Read More »